About the Authors

Josep M. Llibre

jmllibre@flsida.org

Affiliations HIV Unit and "Lluita contra la SIDA" Foundation, University Hospital Germans Trias i Pujol, Badalona, Spain, Universitat Autònoma de Barcelona, Barcelona, Spain

Isabel Bravo

Affiliation HIV Unit and "Lluita contra la SIDA" Foundation, University Hospital Germans Trias i Pujol, Badalona, Spain

Arelly Ornelas

Affiliation Department of Econometrics, Statistics and Economy, University of Barcelona, Barcelona, Spain

José R. Santos

Affiliations HIV Unit and "Lluita contra la SIDA" Foundation, University Hospital Germans Trias i Pujol, Badalona, Spain, Universitat Autònoma de Barcelona, Barcelona, Spain

Jordi Puig

Affiliation HIV Unit and "Lluita contra la SIDA" Foundation, University Hospital Germans Trias i Pujol, Badalona, Spain

Raquel Martin-Iguacel

Affiliation Infectious Diseases Dept, Odense University Hospital, Odense, Denmark

Roger Paredes

Affiliations HIV Unit and "Lluita contra la SIDA" Foundation, University Hospital Germans Trias i Pujol, Badalona, Spain, Universitat Autònoma de Barcelona, Barcelona, Spain, Universitat de Vic (UVic). Vic, Catalonia, Spain

Bonaventura Clotet

Affiliations HIV Unit and "Lluita contra la SIDA" Foundation, University Hospital Germans Trias i Pujol, Badalona, Spain, Universitat Autònoma de Barcelona, Barcelona, Spain, Universitat de Vic (UVic). Vic, Catalonia, Spain

Competing Interests

JML has received research funding, consultancy fees, and lecture sponsorships from or has served on advisory boards for Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Janssen-Cilag, Merck Sharp & Dohme, and ViiV Healthcare. JRS has received research funding, consultancy fees, and lecture sponsorships from and has served on advisory boards for Abbott, Boehringer Ingelheim, Gilead Sciences, Janssen-Cilag, Bristol-Myers Squibb, ViiV Healthcare, and Pfizer. RP has received consulting fees from Pfizer and grant support from Pfizer, Roche Diagnostics, Siemens, Merck and Boehringer-Ingelheim. BC has received research funding, consultancy fees, and lecture sponsorships from and has served on advisory boards during the past 5 years for Abbott, Gilead Sciences, ViiV, Janssen-Cilag, and Merck Sharp & Dohme. The remaining authors declare no potential conflicts of interest. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: JML. Performed the experiments: JML IB AO JRS JP. Analyzed the data: JML AO JP IB. Wrote the paper: JML JRS RP. Reviewed the manuscript draft: RMI BC.